| LEXXW Stock | | | USD 0.25 0.05 25.00% |
Lexaria Bioscience financial indicator trend analysis is infinitely more than just investigating Lexaria Bioscience Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lexaria Bioscience Corp is a good investment. Please check the relationship between Lexaria Bioscience Long Term Debt and its Non Current Assets Total accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
Long Term Debt vs Non Current Assets Total
Long Term Debt vs Non Current Assets Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Lexaria Bioscience Corp Long Term Debt account and
Non Current Assets Total. At this time, the significance of the direction appears to have very week relationship.
The correlation between Lexaria Bioscience's Long Term Debt and Non Current Assets Total is 0.21. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Lexaria Bioscience Corp, assuming nothing else is changed. The correlation between historical values of Lexaria Bioscience's Long Term Debt and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Lexaria Bioscience Corp are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Long Term Debt i.e., Lexaria Bioscience's Long Term Debt and Non Current Assets Total go up and down completely randomly.
Correlation Coefficient | 0.21 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Long Term Debt
Long-term debt is a debt that Lexaria Bioscience Corp has held for over one year. Long-term debt appears on Lexaria Bioscience Corp balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Lexaria Bioscience Corp balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.
Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from Lexaria Bioscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lexaria Bioscience Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lexaria Bioscience Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in interest.
At this time, Lexaria Bioscience's
Enterprise Value Over EBITDA is fairly stable compared to the past year.
Enterprise Value Multiple is likely to climb to 415.56 in 2025, whereas
Issuance Of Capital Stock is likely to drop slightly above 3.5
M in 2025.
Lexaria Bioscience fundamental ratios Correlations
Click cells to compare fundamentals
Lexaria Bioscience Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Lexaria Bioscience fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Lexaria Stock Analysis
When running Lexaria Bioscience's price analysis, check to
measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to
predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.